The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
about
PCSK9 LNA antisense oligonucleotides induce sustained reduction of LDL cholesterol in nonhuman primatesHypercholesterolemia, low density lipoprotein receptor and proprotein convertase subtilisin/kexin-type 9Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease riskPrevention of fatal hepatic complication in schistosomiasis by inhibition of CETPThe application of transcriptomic data in the authentication of beef derived from contrasting production systems.Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal.Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.Familial hypercholesterolemia: the lipids or the genes?Plasma levels of PCSK9 and phenotypic variability in familial hypercholesterolemia.Fatal myocardial infarction at 4.5 years in a case of homozygous familial hypercholesterolaemia.Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian population.Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations.Variable expressivity and co-occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy.Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution.Dementia prevalence, care arrangement, and access to care in Lebanon: A pilot study.The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding.Differences in allele frequencies of autosomal dominant hypercholesterolemia SNPs in the Malaysian population.My road to Damascus: how I converted to the prohormone theory and the proprotein convertases.PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia.Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.Clinical and genetic factors influencing cardiovascular risk in patients with familial hypercholesterolemia
P2860
Q24633470-55881D36-C477-40CB-BA69-09FF6FA33CE1Q26786549-F969270D-CD9B-40D2-ACE4-7B37BD37B678Q27003094-1D888318-E41A-42DD-B22E-B15B240C7015Q27011500-B56E028D-D42B-483A-A74E-7CC796B9BA3EQ31132226-F71C5FBE-7134-426B-843F-7A78467F6A86Q33532632-291B2B24-B349-476E-9187-F1FA760145A8Q34430377-31986992-A4A1-4664-AF5A-1BA54EFB5DEDQ35014525-69E96603-54C6-49AD-9A00-79F6B25A19D3Q35897064-161FAF51-0239-49D8-A8F5-BC680644CCC6Q36433279-12CBFCBC-8D27-4A87-9733-A0C499633C3FQ36634114-8D319D76-973C-4F27-9B36-C55C7F00C410Q36866980-57577947-75C1-47AA-AC30-8097680E98F7Q36902980-7ADC4F93-EB27-4228-A4BC-00B6152FB46CQ37187461-D100A7CD-07E0-41ED-8CFD-5A1EC2302B58Q37887013-A46A3ECD-4C0F-4D32-BE3D-A8B17851DFE2Q38745820-D72F4CBD-5444-4AD7-B2A5-4085D343F123Q41467514-C0879124-92F9-4E70-BE3C-3DD49E0DDBE3Q42908894-C13FBEB9-2DF7-4CE5-8A63-E4681198626EQ46286854-135A225C-B4EF-4420-8597-176F5381239AQ48345564-E3DE3AA1-2F1E-4199-B910-6CCBF40FA1C3Q49241727-316614F7-DBF3-46C0-A306-0BBEBEBFE8CDQ55021529-20E4C45D-3828-470E-9D7C-C9FEBC98323CQ57364764-AF4D5A2B-07F4-40B8-A248-865F95C143AA
P2860
The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@en
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@nl
type
label
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@en
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@nl
prefLabel
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@en
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@nl
P2093
P50
P356
P1433
P1476
The molecular basis of familia ...... e of PCSK9 as a modifier gene.
@en
P2093
Antoine Sarkis
Claudine Junien
Georges Halaby
Hermine Aydénian
Marianne Abifadel
Nabiha Salem
Sandra Corbani
Sélim Jambart
P304
P356
10.1002/HUMU.21002
P50
P577
2009-07-01T00:00:00Z